SIMMEN, KENNETH ALAN,SURLERAUX, DOMINIQUE LOUIS NESTOR GHISLAIN,LIN, TSE-I,LENZ, OLIVER,RABOISSON, PIERRE JEAN-MARIE BERNARD
申请号：
CA2608301
公开号：
CA2608301C
申请日:
2006.05.12
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The present invention relates to the use of pyrido[2,3-d]pyrimidines offormula (I)(see formula I)wherein L, R1, R2 and R3 have specific meaning. The present invention alsorelates to theuse of the compounds of formula (I) as inhibitors of HCV replication as wellas their usein pharmaceutical compositions aimed to treat or combat HCV infections. Inaddition, thepresent invention relates to compounds of formula (I) per se and their use asmedicines.The present invention also concerns processes for the preparation of suchcompounds,pharmaceutical compositions comprising them, and combinations of saidcompoundswith other anti-HCV agents.
